Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success
RSS SUMMARY · AGGREGATED FROM TWSJ
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
World News
Trump and Netanyahu’s Rift Over Lebanon Is Deepening
TWSJ·1h ago·3 min read
Business
Financial Services Roundup: Market Talk
TWSJ·55m ago·3 min read
Tech
Democrats Unveil Flood of AI Proposals in Potential Challenge to Tech Giants
TWSJ·2h ago·3 min read
Business
China Auto Sales Stayed Weak in May
TWSJ·2h ago·3 min read
Related
On this beat
Health
Weight loss drug maker sinks 25% after new safety data spooks investors
CNBC·2h ago·3 min read
Health
Life After A Spinal Injury: A Guide to Physical And Mental Recovery
AOHL·3h ago·3 min read
Health
Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch
TWSJ·5h ago·3 min read
Health
Robert Coles, Pulitzer-Winning Child Psychiatrist, Is Dead at 97
TNYT·13h ago·3 min read